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Summary
Novel mutations in prfA, the gene for the polypeptide
release factor RF1 of Escherichia coli, were isolated
using a positive genetic screen based on the
parD (kis, kid) toxin–antitoxin system. This original
approach allowed the direct selection of mutants with
altered translational termination efficiency at UAG
codons. The isolated prfA mutants displayed a ~10-
fold decrease in UAG termination efficiency with no
signiﬁcant changes in RF1 stability in vivo. All three
mutations, G121S, G301S and R303H, were situated
close to the nonsense codon recognition site
in RF1:ribosome complexes. The prfA mutants
displayed increased sensitivity to the RelE toxin
encoded by the relBE system of E. coli, thus provid-
ing in vivo support for the functional interaction
between RF1 and RelE. The prfA mutants also
showed increased sensitivity to the Kid toxin. Since
this toxin can cleave RNA in a ribosome-independent
manner, this result was not anticipated and provided
ﬁrst evidence for the involvement of RF1 in the
pathway of Kid toxicity. The sensitivity of the prfA
mutants to RelE and Kid was restored to normal
levels upon overproduction of the wild-type RF1
protein. We discuss these results and their utility for
the design of novel antibacterial strategies in the light
of the recently reported structure of ribosome-bound
RF1.
Introduction
Translation termination is an important stage in protein
synthesis which leads to the release of the newly synthe-
sized polypeptide chain from the ribosome. This is initi-
ated when a termination codon in mRNA enters the
ribosomal A site and is recognized by a class 1 release
factor (RF). In bacteria, translation termination requires
the active contribution of two protein release factors, RF1
and RF2 (Scolnick et al., 1968); these factors recognize,
respectively, and with different affinity UAA/UAG or UAA/
UGA termination codons at the decoding centre of the
ribosomalAsite.Aconserved tripeptide motif GGQ in RF1
or RF2 interacts with the peptidyl transfer centre (PTC)
(Frolova et al., 1999) and activates the hydrolysis of the
ester bond between the polypeptide chain and the tRNA
at the PTC, thereby releasing the newly synthesized
polypeptide chain.
Speciﬁc recognition of termination codons by RF1 and
RF2 involves speciﬁc tripeptide motifs, PxT for RF1 or
SPF for RF2 (Ito et al., 2000), which are present in a
central domain of the proteins. The tripeptide motifs were
ﬁrst suggested to be responsible for recognizing the last
two nucleotides of the three stop codons (Ito et al., 2000),
but recent structural studies indicate that they interact with
the ﬁrst two nucleotides (Laurberg et al., 2008) and
explain in part the remarkable accuracy with which the
ﬁrst stop codon nucleotide, an invariant uridine, is recog-
nized (Freistroffer et al., 2000). Discrimination against
purines in the ﬁrst stop codon position implicates residues
near the tip of a helical ﬁnger (a-helix 5) present in the
central domain (Laurberg et al., 2008). Two residues near
the PxT motif, Q185 and T198 in Escherichia coli RF1,
discriminate against pyrimidines in the third stop codon
position (Laurberg et al., 2008). Interactions of RF1 or
RF2 with a third factor, RF3-GTP or GDP, at the GTP-
associated centre of the 50S ribosomal subunit, are also
required for the ﬁnal detachment of the class 1 RFs from
the ribosome (Freistroffer et al., 1997; Zavialov et al.,
2001; 2002; Gao et al., 2007).
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motif conserved in class I RFs has been provided by
crystal structures of RF1 and RF2 in complex with the
ribosome (Petry et al., 2005; Laurberg et al., 2008), and
by molecular dynamics simulations of peptide release
(Trobro and Aqvist, 2007). The GGQ motif, together with
A76 of the P-site tRNA, is instrumental in co-ordinating
the water molecule that initiates a nucleophilic attack on
the peptidyl-tRNA ester bond. Following the detachment
of the RF from the ribosome the subsequent action of the
ribosomal releasing factor RRF and the elongation factor
EF-G (Karimi et al., 1999; Gao et al., 2007) leads to the
de-assembling of the ribosomal subunits, which can then
be recycled and reassembled in a new translation initia-
tion event.
Pausing of a bacterial ribosome due to limitations in
tRNA can lead to cleavage of mRNA at a site within or
immediately adjacent to the A-site codon; the ribosome
participates in this cleavage in an, as yet, undeﬁned way
(Hayes and Sauer, 2003; Sunohara et al., 2004). Breaks
at UAG and UGA stop codons induced by ribosome stall-
ing due to the reduced activity of RF1 have been reported
(Li et al., 2007). Breaks in the mRNA at UAG termination
codons at theAsite can also be induced by the RelE toxin
encoded by the bacterial toxin–antitoxin (TA) system
relBE. The cleavage occurs preferentially between the
second and third nucleotides of UAG termination codons
in the ribosomalAsite implying the concerted action of the
RelE toxin and the ribosome (Pedersen et al., 2003). The
RelE toxin is activated under amino acid or carbon source
limitation by a mechanism which involves the enhanced
decay of the RelB antitoxin protein (Gerdes et al., 2005).
Consistent with this, RF1, which preferentially recognizes
this termination codon at the A site, can protect against
the RelE cleavage in vitro (Pedersen et al., 2003). Cleav-
age of mRNAin all the above cases leads to the stalling of
the ribosome at the end of the non-stop mRNA, and can
eventually inhibit protein synthesis as in the case with
RelE. Stalled ribosomes are released by the intervention
of transfer-messenger RNA (tmRNA), which provides a
new stop codon and tags potentially harmful truncated
peptides for rapid degradation (Moore and Sauer, 2007);
this, in turn, feeds amino acid pools [see Discussions by
Gerdes et al. (2005) and by Condon (2006)].
The kis–kid antitoxin–toxin system of plasmid R1 codes
for an unstable antitoxin Kis and a stable toxin Kid. Kid,
like RelE, is also a speciﬁc endoribonuclease and an
inhibitor of translation, but unlike RelE, Kid can cleave
RNA in the absence of ribosomes and does so at the core
sequence UA(A/C) preferentially but not exclusively in
single-stranded regions (Zhang et al., 2004; Munoz-
Gomez et al., 2005). Cleavage occurs by a mechanism
similar to the RNaseAand RNase T1, involving the Uracyl
2′-OH group and producing two fragments, with a 2′:3′-
cyclic phosphate group at the uracyl and a free 5′-OH
group at the adenosine respectively. Cleavage of RNA in
the absence of ribosomes can also introduce non-stop
mRNA in the translation machinery, a proposal that is
consistent with the increased sensitivity to the Kid toxin
observed in tmRNA-deﬁcient strains (Munoz-Gomez,
2004).
While searching for E. coli mutations affecting the toxic
activity of the Kid protein, we developed a genetic screen
that was based on the selection of bacteria that could
survive in the presence of a mutant parD locus encoding
a functional Kid toxin and a truncated and inactive anti-
toxin resulting from an amber termination mutation in the
kis antitoxin gene (Bravo et al., 1988). As a consequence,
the isolation of suppressors leading to the efficient bypass
of the amber mutation in kis was one anticipated
response. Unexpectedly, however, these mutations were
found to be novel and to be exclusively targeted to the
prfA gene encoding the RF1 protein. Our work reported
here shows that these mutations reveal novel functional
connections between the activity of bacterial toxins and
translation termination factors.
Results
Isolation of novel prfA mutants in E. coli
Our work was initially focused on a search for E. coli
mutants resistant to the cytotoxic activity of Kid. For this
purpose, we used a double selection approach inspired
by the work by Bernard and Couturier (1992), which led to
the isolation of mutations in the gyrA gene encoding the A
subunit of DNA gyrase, the bacterial target of the CcdB
toxin. Two compatible plasmids were employed, pKK1120
and pAB1120, that confer resistance to tetracycline and
kanamycin, respectively, and which both contain the
mutant parD operon kis74 (amber), kid+ (Table 1). In the
absence of suppression of the kis74 mutation, an inactive
form of the Kis antitoxin is produced, thus leading to a
Kid-dependent inhibition of colony formation. In a ﬁrst
round of selection, E. coli cells treated with the mutagen
2-aminopurine were transformed with the pKK1120
plasmid and cultured in medium containing tetracycline.
To enrich for potential Kid-resistant mutants, a second
round of selection was carried out by transforming the
cells with the pAB1120 plasmid and plating on medium
supplemented with kanamycin. To discard possible muta-
tions affecting either the kid gene itself or its regulatory
elements present in the plasmid, the toxicity of the resi-
dent plasmids was assessed by extracting the plasmid
DNA and retransforming fresh wild-type E. coli cells.
Mutants that exhibited growth despite containing a toxic
plasmid were kept for further characterization.
The mutations were mapped to the region between 22
and 32 min on the E. coli chromosome using a collection
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the genetic mapping of the mutations, the mutant strains
were used as recipients in P1 transduction experiments
performed using different donor strains bearing Tn10
transposon insertions at regular intervals between
minutes 22 and 32 on the chromosome. For one of the
mutants we observed that the pAB1120-resistance phe-
notype was lost at high frequency upon transduction from
a donor containing the Tn10 at position 26.61 min. In
order to isolate the mutant gene, fragments of the chro-
mosome of the mutant strain (hereafter the KR19 strain),
generated by partial Sau3A restriction digestion, were
cloned into a low-copy-number mini-F, pMLM1 (Lemon-
nier et al., 2000). E. coli cells were transformed with this
library, pooled and subsequently transformed with the
pAB1120 plasmid. Mini-F plasmids carrying fragments
that conferred resistance to pAB1120 were isolated and
their chromosomal insert sequenced. All the sequenced
fragments consisted in a chromosomal region enclosing
the prfA gene encoding polypeptide release factor RF1.
The localization of this gene at 27.2 min in the E. coli
chromosome was consistent with the results of the Hfr
mapping. Subsequently, the sequencing of the prfA region
of KR19 and of several independent mutants isolated by
this approach revealed that in all cases mutations in the
prfA gene could be detected. Four independent mutants,
hereafter called KR2, KR4, KR17 and KR19, were kept for
subsequent studies. Sequencing analysis revealed that
the mutations consisted of single-base G-C or A-T transi-
tions, as expected from a 2-aminopurine mutagenic treat-
ment (Ronen, 1980). Strains KR2 and KR19 were found
to bear the same mutation, prfA301, which led to a Gly to
Ser amino acid change at position 301 of RF1. Strain KR4
carried the mutation prfA303, in which an Arg has
changed to Ser at position 303 of RF1. Finally, KR17
strain carried the mutation prfA121, a Gly to Ser change at
position 121 of RF1.
The prfA mutants are unable to complement a prfA(ts)
mutation unless they are overexpressed
To assess whether the isolated prfA mutants were
affected in their translation termination activity in vivo,w e
performed a complementation assay using a conditional
temperature-sensitive E. coli mutant, MRA8 prfA1(ts)
(Ryden and Isaksson, 1984; Zhang et al., 1994). The
strain was transformed with the pBAD18 plasmid deriva-
tives pELI01, pELI02, pELI03 and pELI04, which carried
the alleles prfA121, prfA wt, prfA301 and prfA303, respec-
tively, under the control of the arabinose-inducible pro-
moter pBAD (Guzman et al., 1995). MRA8 was also
transformed with pBAD18 as a control. At basal expres-
sion levels (i.e. in the absence of arabinose), wild-type
prfA expressed from pELI02 was able to complement the
prfA1(ts) mutation at the non-permissive temperature of
42°C, whereas none of the mutants was able to do so
(Fig. 1, left). When expression of the prfA alleles was
induced by adding arabinose to the medium, the growth of
strain MRA8 at 42°C was signiﬁcantly recovered for all the
mutants tested (Fig. 1, right). Since overexpression of the
mutant proteins was able to achieve complementation,
these results indicated that the mutations signiﬁcantly
decreased, but did not abolish, the efficiency of transla-
tional termination by RF1.
Decreased translation termination in vivo leads to
readthrough of stop codons
Since the mutations affected RF1, which speciﬁcally rec-
ognizes UAG (amber) stop codons, a likely explanation
Table 1. Plasmids used and constructed in this work.
Plasmid Relevant features Reference
pAB1120 R1, copB
-, parD [kis74, kid(wt)], kan Bravo et al.
pKK1120 pACYC184-derivative plasmid, parD [kis74, kid(wt)], tet This work
pBAD18 pBR322-derivative expression vector, amp Guzman et al. (1995)
pELI01 pBAD18, Para::prfA121, amp This work
pELI02 pBAD18, Para::prfAwt, amp This work
pELI03 pBAD18, Para::prfA301, amp This work
pELI04 pBAD18, Para::prfa304, amp This work
pELI05 pFUS2, Para::kis, kan This work
pELI06 pFUS2, Para::kis74, kan This work
pELI07 pNDM220, Plac::relE, amp This work
pELI08 pFUS2, Para::prfAwt, kan This work
pELI09 pFUS2, Para::relB, kan This work
pET80 parD [kis(wt), kid(wt)], kan Bravo et al. (1988)
pMLM1 mini-F, repFIA+, sop+, cat Lemonnier et al. (2000)
pFUS2 pFUS-derivative expression vector, kan Lemonnier et al. (2000)
pNDM220 miniR1-derivative expression vector, amp Gotfredsen and Gerdes (1998)
pSS100 pNDM220, Plac::kid, amp Santos_Sierra et al. (2002)
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was the readthrough of the kis74 amber mutation, which
would allow the production of an active, full-length
antitoxin. Wild-type E. coli cells and KR19 mutant bacteria
were transformed with either the plasmid vector pFUS2,
or its derivatives pELI05 and pELI06 bearing the wild-type
kis and the mutant kis74 alleles, respectively, placed
under the control of the arabinose-dependent pBAD pro-
moter (Guzman et al., 1995). Following overexpression of
the kis alleles by addition of arabinose to the cultures, cell
lysates were prepared and analysed by Western blot
using anti-Kis antibodies (Fig. 2).Aband corresponding to
the full-length Kis protein was detected in the lysates
obtained from wild-type and KR19 cells carrying the
pELI05 (kis+) plasmid. This band was not present in
lysates of wild-type cells containing pELI06, which pro-
duced a Kis protein of a lower size resulting from the
truncation of the protein at site 74. Note that this Kis74
protein could not be well detected because it co-migrated
with a lower non-speciﬁc band. In strain KR19 containing
pELI06, readthrough of the stop codon at position 74
yielded a Kis protein of higher molecular weight, most
likely a full-length protein, indicating a decreased in vivo
efficiency of translation termination by the mutant RF1
protein at UAG stop codons. Similar results were also
obtained for the KR17 mutant (data not shown).
RF1 mutations strongly reduce the speciﬁc termination
activity of RF1 at UAG codons
Altogether, these results suggested that the prfA mutant
strains KR4, KR17 and KR19 were deﬁcient in translation
termination activity at UAG codons. This hypothesis could
be tested using a system described by Curran and Yarus
(1989) and developed into a convenient and precise
assay system by Poole et al. (1995). This system is based
on competition between translational termination and
ribosomal frameshifting at the frameshift site present in
E. coli prfB.At this site, an in-frame UGAstop codon in the
mRNA is bypassed by a +1 ribosomal frameshift, stimu-
lated by the presence of a Shine–Dalgarno sequence six
nucleotides upstream of the stop codon. In the assay
system, the RF2 frameshift window is fused to the malE
gene, expressed from a plasmid. Termination and +1
frameshifting lead to proteins of 43.9 and 52.0 kDa,
respectively (Fig. 3A), that are separated by SDS gel
electrophoresis and detected by Western blotting, binding
of anti-MalE antibody and interaction with 125I-labelled
Protein A. The ratio of the termination product to the
Fig. 1. Complementation of a temperature-sensitive prfA mutation. MRA8 [prfA1(ts)] strain was transformed with the plasmids pELI01
(prfA121), pELI02 (prfAwt), pELI03 (prfA301) and pELI04 (prfA303). Expression of the prfA alleles in these plasmids was placed under the
control of a promoter whose activity could be induced by adding arabinose into the medium.
A. Uninduced cultures were grown at 42°C for up to 160 min.
B. Same experiment but arabinose (1% ﬁnal) was present in the medium to induce the expression of the different prfA alleles.
Fig. 2. In vivo readthrough of the kis74 amber mutation in KR19
strain. Western blot analysis was performed using different cell
extracts as described in Experimental procedures. The black arrow
indicates full-length Kis protein. Lanes 1, 3 and 5, cell extracts from
strain MC1061 bearing pFUS2, pELI05 (kis) and pELI06 (kis74)
plasmids, respectively; lanes 2, 4 and 6, cell extracts from strain
KR19 carrying pFUS2, pELI05 and pELI06 plasmids, respectively;
lane 7, puriﬁed his-tagged Kis protein. The thick band at the bottom
of the gel is a non-speciﬁc product present in whole-cell lysates.
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efficiency at different stop signals or in different strains.
The activity of the prfA mutant strains was tested at
UAG stop codons in two contexts: UAGAand UAGU, both
less favourable for termination than the most common
UAG stop signal, UAGG. Western blots of this assay are
shown in Fig. 3B, and the termination rate constants rela-
tive to frameshifting in Table 2. Expression of the fusion
Fig. 3. Efficiency and levels of RF1 in prfA mutant strains in vivo. Termination was measured by competition with frameshifting at the shifty
site present in the E. coli prfB gene (Poole et al., 1995).
A. A region of 23 nucleotides from the prfB gene around the frameshift site was fused to the malE gene present in a plasmid under the control
of the P-tac promoter. Frameshifting (+1) of the ribosome paused at the in-frame stop signal allows translation to continue into a sequence
derived from the lacZ gene. The wild-type tetranucleotide stop signal TGAC was replaced by the tetranucleotides TAGA or TAGU.
B. Expression of the MalE fusion products was induced in vivo in the parental strain MC1061 and each of the mutant strains KR4, KR17 and
KR19 with IPTG for 2 h. The protein products of termination and frameshifting present in 3 or 6 ml of cell extract (see Experimental
procedures) were separated on SDS gels and visualized by Western blotting using anti-MalE antibodies and
125I-labelled protein A.
C. The amounts of RF1 in parental and prfA mutant strains were determined by quantitative Western blotting with rabbit anti-RF1 antibodies
and
125I-labelled protein A.
Table 2. Termination rate at UAG codons and quantities of RF1 in prfA mutant strains.
MC1061 KR4 KR17 KR19
RF1 mutation – R303H G121S G301S
Termination rate at UAGA 1.30 0.18 0.15 0.14
Termination rate at UAGU 1.42 0.16 0.06 0.12
Relative quantity of RF1 100 80 85 85
Data are obtained by quantiﬁcation of Western blots such as those shown in Fig. 3. Termination rate at UAGAand UAGU stop signals is expressed
relative to +1 frameshifting in a frameshift window derived from the RF2 frameshift site. The quantity of RF1 in mutant strains, measured by reaction
with anti-RF1 antibodies, is expressed as a percentage of that found in the parental strain MC1061.
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growth, which accounts for the reduced amount of fusion
protein in these strains; for reasons that are unclear the
inhibitory effect was more pronounced with the UAGA-
containing fusion. The values found for the termination
rate in parental strain MC1061 are close to those reported
by Poole et al. (1995) but lower than those of Mora et al.
(2007) in other E. coli K12 strains. It should be recalled
that strain MC1061 is a streptomycin-dependent strain,
grown in the presence of streptomycin, and that this is
likely to inﬂuence the kinetic parameters for translation
and translation termination. As seen in Table 2 (rows 2
and 3), termination rates for all three mutants at both
UAGA and UAGU signals were strongly reduced with
respect to the wild type by an average factor of about 10.
Two mechanisms might explain this result: the muta-
tions may affect the folding or stability of RF1, resulting in
a strongly reduced amount of RF1 in the cell.Alternatively,
the activity of the protein may be reduced compared with
that of the normal factor. To resolve this question, the
amount of RF1 present in the prfA mutant strains was
compared with the parental strain by quantitative Western
blotting using anti-RF1 antibodies. The results (Fig. 3C,
Table 2, row 4) showed that the reduction in the amount of
RF1 in the mutant strains was quite modest (15–20%),
insufficient to explain the 10-fold drop in termination rate
in the cells; the major part in this drop must therefore be
due to reduced activity of the mutant factors.
The small decrease in the amount of RF1 found in the
mutant strains suggested that the mutant factors were not
strikingly less stable than the wild-type factor. This con-
clusion might however be invalid if an autocontrol mecha-
nism were present in cells, with the consequence that a
lowered peptide release activity were to lead to a higher
rate of synthesis of the RF. Such an autocontrol mecha-
nism does exist in the case of RF2 in E. coli and in about
70% of microorganisms for which genome sequences are
known (Baranov et al., 2002), based on the competition
between termination and frameshifting that we have
used to assay termination efficiency. The prfA gene is
expressed from the promoter of the upstream gene,
hemA. It has been suggested that E. coli and Salmonella
may possess a mechanism for the autocontrol of RF1
synthesis, dependent upon readthrough of the weak
UAGC tetranucleotide stop signal of the hemA gene,
coupled with a suboptimal ribosome binding site for prfA
expression (Elliott, 1989). The hypothesis suggests that
RF1 synthesis may result to a signiﬁcant extent from
ribosomes that read through the hemA stop signal, trans-
late the intergenic region, terminate just short of the prfA
initiation codon and resume translation without dissociat-
ing from mRNA. To test this hypothesis, we constructed
translational fusions with lacZ extending from the pro-
moter region of hemA to codon 13 of prfA, analogous to
those described by Dahlgren and Ryden-Aulin (2004),
and studied the effect on b-galactosidase synthesis of
mutating the hemA stop signal or introducing mutations in
RF1. The results showed that even in the case of the RF1
mutants described in this article, little RF1 is in fact syn-
thesized in E. coli by the proposed readthrough mecha-
nism (L. Mora, unpubl. data). These results further conﬁrm
that the detected levels of the RF1 mutants reﬂect a minor
effect on stability and therefore that the isolated mutations
do not affect substantially the stability of RF1.
prfA mutation leads to hypersensitivity to Kid and
RelE toxins
SinceRF1wasshowntoprotectfromRNAcleavagebythe
RelE toxin in vitro (Pedersen et al., 2003), we hypoth-
esized that the mutant RF1 strains should be particularly
responsive to the activity of RelE in vivo. For this analysis
we selected the prfA mutant KR19 as this mutant showed
the lowest overall termination efficiency in the assays (see
Table 2). We produced the RelE protein in this mutated
prfA strain and compared the levels of cytotoxicity with
those achieved in a wild-type E. coli background. To gain
insight into the mechanism of RF1-dependent protection,
weperformedaparallelcontrolexperimentinwhichtheKid
toxin was produced in place of RelE. Figure 4 shows the
cytotoxiceffectsofbothKidandRelEproteinsoverthewild
type, MC1061, and the mutant strain KR19 bearing the
plasmidspNDM220(vector),pELI06(kid)orpELI07(relE).
Figure 4Aand D shows that the growth of the strains in the
absenceofinductionofthetoxinsisunaffected.Thepartial
induction of toxins Kid or RelE with a less-than-saturating
concentration of IPTG (100 mM) inhibited cell growth in
prfA mutant strains but not in the wild-type strain MC1061
(Fig. 4B, rows 4 and 6 compared with rows 3 and 5). This
suggested that KR19 was hypersensitive to both toxins.
When this strain was transformed with pELI08 (prfAwt),
normal sensitivity to toxins was restored (Fig. 4C, rows
3–6), suggesting a speciﬁc effect of the mutations in prfA
on the hypersensitivity to the toxins. The growth inhibition
of the prfA mutants by the Kid and RelE toxins was neu-
tralized when their respective antitoxin genes kis and relB
were coexpressed (Fig. 4E, rows 3–6). Altogether these
experiments brought to light a novel and speciﬁc functional
interplay between RF1 and the Kid and RelE toxins.
Both RelE and Kid toxins are inhibitors of protein
synthesis. We therefore evaluated the effect of these
toxins on the de novo protein synthesis in the prfA mutant
and wild-type strains at the suboptimal induction condi-
tions mentioned above. The results (Fig. 5) indicated that
indeed the RelE and Kid toxins inhibited protein synthesis
in the prfA mutant but not in the wild-type strain. The
enhanced inhibition of protein synthesis by Kid and RelE
was prevented when their cognate Kis and RelB antitox-
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cating as in the previous assay that the inhibitory effect on
protein synthesis is speciﬁc to the activity of the toxins.
Protection by the RF1wt protein in this assay was less
efficient, which is likely a reﬂection of the more speciﬁc
interaction of a toxin with its cognate antitoxin (data not
shown). Altogether, the increased efficiency in protein
synthesis inhibition was consistent with the enhanced
cytotoxic effect displayed by the Kid and RelE proteins in
the mutant prfA background.
To test whether the extra-sensitivity to the toxins of the
prfA mutants was an indirect consequence of a general
stress on the translation apparatus we ﬁrst compared the
sensitivity of the wild type and mutant strain to antibiotics
acting on translation, such as chloramphenicol or tetracy-
cline, inhibitors of the peptidyl transferase activity or
of aminoacyl tRNA binding respectively (Chopra and
Roberts, 2001; Hansen et al., 2003). The sensitivity to
different aminoglycosides (kanamycin, gentamicin and
paromomycin) was also tested. These family of antibiotics
interact at the A site on the 30S subunit of the ribosome
affecting codon–anticodon recognition and translocation
of tRNAbetween theAand P sites (Kotra et al., 2000). We
obtained the following results (see Fig. 6): (i) there were
no differences in the sensitivity of the wild-type and prfA
strains to chloramphenicol and tetracycline, thus ruling
out increased sensitivity to Kid and RelE as a circunstan-
cial consequence of a general stress on the translation
apparatus imposed by the prfA mutations, and (ii) the
mutant strain was more sensitive than the parental one to
kanamycin, and to the other aminoglycosides tested. This
is somehow an expected result as these antibiotics inter-
act with a region that is overlapping with the domain of
interaction of RF1 (see Discussion).
As an additional control to test possible unspeciﬁc
effects of the prfA mutation on other cellular processes,
we used Nalidixic acid (an inhibitor of DNAGyrase and an
inductor of the SOS response) or Rifampycin (an inhibitor
of RNA polymerase and therefore of transcription). No
Fig. 4. Hypersensitivity of the prfA mutant strain KR19 to the Kid and RelE toxins and neutralization by cognate antitoxins and by prfAwt
overexpression. Parental MC1061 and prfA mutant KR19 strains bearing the pNDM220 plasmid vector (lanes 1 and 2) or its derivatives
encoding Kid (lanes 3 and 4) and RelE (lanes 5 and 6) toxins were grown exponentially to an A600 of 0.4 in LB medium. Serial dilutions (10
-1
steps from left to right) of the different cultures were spotted in LB solidiﬁed medium. In (B) and (C), IPTG (100 mM) was included in the plates
to induce the expression of the Kid and RelE toxins from the plasmids. In (A) and (D), the same experiment was performed but IPTG was
omitted. Speciﬁcity controls were carried out by transforming the cells with plasmid pELI08 (prfAwt) (C and D) or with the plasmids encoding
the respective antitoxins to Kid and RelE, namely plasmids pELI05 (kis) and pELI09 (relB) (E). The plates were incubated at 30°C and
photographs were taken after 18 h incubation.
Fig. 5. Inhibition of protein synthesis in vivo by the Kid and RelE
toxins. Strains MC1061 (top) or KR19 (bottom) were transformed
with plasmids as indicated: lane (1) plasmid vector pNDM220, lane
(2) pSS100 (kid), lane (3) pELI07 (relE), lane (4) pSS100 (kid) and
pELI05 (kis), lane (5) pELI07 (relE) and pELI09 (relB). When
relevant, expression of the toxin and antitoxin genes was triggered
by adding IPTG (100 mM) and arabinose (0.5%) to the medium
respectively. The proteins synthesized at time 0 or 60 min after the
induction of the toxin and antitoxin genes were fractionated by
SDS-PAGE (12.5%) and identiﬁed by autoradiography as described
in Experimental procedures.
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sensitivity to these inhibitors were found (Fig. 6). This
further supports the speciﬁcity of the increased sensitivity
to the RelE and Kid toxin observed in the mutants.
Discussion
Inthisarticlewereporttheisolationandcharacterizationof
novelmutationsinprfAaffectingthetranslationtermination
factor RF1.As previously described these mutations were
selected by means of a novel TA system-based genetic
screen leading to the efficient counter-selection of cells
with intact translation termination capacities. The three
mutant residues isolated in RF1 are grouped quite closely
together and are nearby the region of RF1 known to be
involved in stop codon recognition (Fig. 7). This includes a
tripeptide motif (PxT, 188–190 in RF1, SPF, 205–207 in
RF2) (Ito et al., 2000) important in the recognition of the
ﬁrst and second stop codon nucleotides (Laurberg et al.,
2008)andaminoacidresiduesatthetipofhelixa5(shown
in blue in Fig. 7) in RF1 and RF2, which help discriminate
against purines at the constant ﬁrst position U of stop
codons (Petry et al., 2005; Laurberg et al., 2008). One of
the mutations, G121, is present at the tip of this helix, and
iswithinabout6 Åoftheﬁrsttwonucleotides,U4andA5of
the mRNA stop codon (Fig. 8, Table 3). Mutation R303 is
close to A1492 and A1493 in 16S rRNA, involved both in
recognition of sense codons in the A site by tRNA (Ogle
et al., 2001; Ogle and Ramakrishnan, 2005) and in trans-
lation termination (Laurberg et al., 2008), as well as to
other adjacent nucleotides. Both R303 and G301 are close
toribosomalproteinS12(Fig. 8,Table 3).MutationsinS12
areknowntoaffecttheaccuracyofstopcodonrecognition.
Thus all three mutations are situated close to the stop
codon recognition site, which is consistent with their effect
Fig. 6. Sensitivity assays of the KR19 (prfA301) and the parental
strain MC1061 to different antibiotics. Parental MC1061 and prfA
mutant KR19 strains were grown at 30°C to an A600 of 0.4 in LB
medium. Serial dilutions (10
-1 steps from left to right) of the
different cultures were spotted in LB solidiﬁed medium (lane LB) as
a positive control or in the same medium supplemented with the
different antibiotics: tetracycline (Tc, 0.1 mgm l
-1), chloramphenicol
(Cm, 0.5 mgm l
-1), kanamycin (Km, 1.0 mgm l
-1), gentamicin
(Gm, 0.5 mgm l
-1), paromomycin (Par, 1.0 mgm l
-1), nalidixic acid
(NA, 1.0 mgm l
-1) and rifampycin (Rif, 1.0 mgm l
-1). Concentrations
of the different antibiotics close to their minimal inhibitory
concentrations were used. The plates were incubated at 30°C and
photographs were taken after 18 h incubation.
Fig. 7. Positions of the mutations in RF1 in relation to domains
and sequence motifs of functional importance. The positions of
residues G121, G301 and G303 for which mutants are found are
shown space-ﬁlled in red (G121 and R203) or yellow (G301) on a
model of the open form of Thermotoga maritima RF1 in ribbon
representation (Vestergaard et al., 2005). The a5 helix, which has
G121 at the tip, is shown in violet. The PxT motif implicated in
recognition of the stop codon (Ito et al., 2000) is shown space-ﬁlled
in pink, and residues T198 and Q185 interacting with the third stop
codon nucleotide (Laurberg et al., 2008) are space-ﬁlled in light
blue. The GGQ motif that interacts with the peptidyl transferase
centre and triggers peptidyl-tRNA hydrolysis is shown space-ﬁlled
in blue.
Table 3. Components of mRNA, 16S rRNA and proteins of the 30S
ribosomal subunit within about 6 Å of the mutant residues in RF1.
Mutant residue mRNA 16S rRNA 30S proteins
G121 U4, A5 A1493, G1494
G301 S12: T43
R303 A1491, A1492 S12: T43, P44
The nearby components were identiﬁed using the structure ﬁle of the
RF1:70S ribosomal complex (Laurberg et al., 2008). See also Fig. 8.
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RF1. It would be of interest to study their effect on the
accuracy of stop codon recognition.
These novel prfA mutants show increased sensitivity to
the RelE and Kid toxins. This phenomenon, detected both
in growth and in protein synthesis assays, and the sup-
pression of this sensitivity by the overproduction of prfAwt
in vivo revealed an unexpected conﬂuence in the pathway
of action of these two toxins. Previous reports showed
that the RelE toxin acts as an endoribonuclease in con-
certed action with the ribosome to cleave at the UAG
termination codon at the A site of the ribosome, thus
leading to translation inhibition. Consistent with this it was
found that RF1 prevents RNAcleavage by this toxin (Ped-
ersen et al., 2003). RelE seems to have a shape similar to
the C-terminal region of translation elongation factor EF-G
(Takagi et al., 2005), which could explain its access to the
UAG codon in the A site of the ribosome. The protection
conferred by RF1 against the action of RelE likely reﬂects
a competition for the same substrate. The mutations could
affect this competition ultimately favouring the action of
the toxin. A similar explanation could account for the
extra-sensitivity of the prfA mutant to paromomycin and
other aminoglycosides, which interact with the 30S
subunit of the ribosome at a region overlapping with the
site of interaction of RF1. Paromomycin binding to 30S
ribosomes directly displaces A1492 and A1493 from 16S
rRNA helix 44 to a bulged-out state characteristic of ribo-
somes containing cognate tRNA in the A site (Ogle et al.,
2001). The modes of binding of kanamycin and gentami-
cin to the ribosome are similar (Francois et al., 2005). The
extrahelical position of A1493 sterically impedes RF1
binding (Laurberg et al., 2008), explaining the competitive
inhibition of termination by paromomycin (Youngman
et al., 2007). These aminoglycosides therefore introduce
perturbations into the same region of the decoding site as
the RF1 mutations we describe here, suggesting that the
increased sensitivity of the mutant strains to the antibiot-
ics is due to an accumulation of factors interfering with
stop codon recognition by RFs.
Unlike RelE, the Kid and ChpAK (MazF) toxins are able
to cleave RNA in the absence of ribosomes (Zhang et al.,
2003; 2004; Munoz-Gomez et al., 2004; 2005) following a
mechanism similar to the one described for RNase A and
RNase T1 (Christensen et al., 2003; Pedersen et al.,
2003; Kamphuis et al., 2006). Since the structure of the
Kid protein is clearly different from that of RelE, similarities
in their mechanisms to access the A site of the ribosome
seem unlikely. It is noteworthy however that the Kid toxin
can cleave the minimal substrate UpA which is part of the
termination codon UAG/A (Kamphuis et al., 2006). It
remains to be seen if the hypersensitivity to Kid observed
in the prfA mutants could be due to interactions between
Kid and RF1, which remain to be elucidated. Alternatively,
in view of the fact that reduced activity of the RF1 can
induce ribosome stalling at the stop codon and subse-
quent mRNA cleavage (Li et al., 2007), the increased
toxicity of the prfA mutants to the Kid toxin could also be
due to an enhancement of this stalling. Whatever the
mechanism, it seems clear that the increased sensitivity
of the prfA mutants to aminoglycosides and to the Kid and
RelE toxins is an speciﬁc effect of these mutations rather
than the unspeciﬁc consequence of a general stress on
translation induced by them. This result provided the ﬁrst
evidence for the involvement of RF1 in the pathway of Kid
toxicity.
The new prfA mutants contributed to showing that a
post-transcriptionalmechanismisnotinvolvedinmaintain-
Fig. 8. Ribosomal and mRNA components
near to mutant residues in RF1. Components
near residues G121, G301 and R303 in
E. coli RF1 are shown, based on the 3.2 Å
resolution crystal structure of Laurberg et al.
(2008) of Thermus thermophilus RF1 bound
to homologous 70S ribosomes in the
presence of a short mRNA (5′-GGC AAG
GAG GUA AAA A16U17G18 U19A20A21 AAA
AAA-3′; stop codon in bold; nucleotides
16–21 are shown in yellow) and P- and E-site
bound tRNA
Met
f. The RF1 polypeptide is
shown as a green ribbon (except for helix a5,
in blue), with mutant residues space-ﬁlled
(G121: red, G301: orange, R303: green);
residues are numbered as in E. coli RF1.
Residues in RF1 involved in stop codon
recognition are also shown space-ﬁlled
(P188 and T190: rose, Q185 and T198: blue).
Nucleotides 1491–1498 in 16S rRNA are
shown in grey, and ribosomal protein S12 is
shown as a turquoise ribbon. See Table 3 for
more information about near neighbours of
the mutant residues in RF1.
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used to further explore the contribution of new residues
close to the RF decoding region in the recognition of the
termination codons and/or in the transmission of the signal
that activates the transpeptidase of RF1 at the PTC distal
site. In addition, the experiments reported provide the ﬁrst
in vivo evidence for a functional interaction between the
RelE toxin and the RF1 protein. Furthermore, evidence is
provided for a role of translation termination factors in the
cytotoxicity pathway of the Kid toxin. The results in turn
reveal an unexpected functional conﬂuence between two
distinct families of bacterial toxins, namely the RelE and
Kidfamilies.Similaritiesanddifferencesinthesepathways
remain to be fully established. The hypersensitivity of the
prfA mutants to the RelE and Kid toxins also opens the
possibility of exploring their effects on other toxins belong-
ing to the kis–kid/ccd and the relBE/parDE superfamilies
(Gerdes et al., 2005). These include toxins targeting DNA
gyrase such as CcdB and ParE in addition to toxins which
actsonRNAasKidandRelE.Intheoryitcanbeanticipated
that the prfA mutants should also be extra-sensitive to the
RNase-type toxins of the family but not to the toxins
targetingtheDNAGyrase.Finally,theresultsandmethods
reported here provide a rationale for the design of screen-
ing approaches to isolate inhibitors of RF1 activity. Such
compoundswouldlikelypotentiatetheantibacterialactivity
of TA systems. Most interestingly, some antibiotics have
been reported to speciﬁcally activate TA systems (Sat
et al., 2001). In this respect as well, compound drugs
inhibiting RF1 activity would be particularly appealing as
they would provide a back-up induction of TA toxicity in
antibiotic-resistant strains. Novel therapeutic alternatives
against drug-resistant pathogens are urgently needed and
the work reported here certainly opens new avenues
towards that goal.
Experimental procedures
Bacteria strains
Escherichia coli K-12 strains used in this work are described
in Table 4.
Genetic screen
Escherichia coli K-12 bacteria (strain MC1061) were sub-
jected to mutagenesis following treatment with 2-aminopurine
as described by Miller (1972). The treated bacteria were
made electrocompetent and were electroporated with
plasmid pKK1120 using a Bio-Rad MicroPulser
TM and follow-
ing the manufacturer’s instructions. The cells were allowed to
recover by shaking in SOC (Hanahan, 1983) medium for 1 h
at 37°C. After a brief centrifugation, the cells were
re-suspended in LB medium (Miller, 1972) containing tetra-
cycline (10 mgm l
-1) and incubated at 37°C with aeration for
14 h. After two washes in saline, the cells were rendered
electrocompetent as described above and were electropo-
rated with plasmid pAB1120. The cells were recovered in
SOC medium and were spread on LB agar plates containing
kanamycin (50 mgm l
-1) and streptomycin (200 mgm l
-1). The
plates were incubated at 37°C for more than 18 h.
Plasmid construction
Plasmids used and constructed in this work are listed in
Table 1. To construct the pBAD18-derivative plasmids
(Table 1), PCR fragments were generated using primers PRL
(+)( 5 ′-GACAGCTAGCGGCTGGAGTA-3′; NheI site under-
lined) and PRR (-)( 5 ′-GGTAGCATGCTCCAGCAGGATTTC-
3′; SphI site underlined) and genomic DNA originated from
the wild-type strain as well as from the different mutants as
templates. The resulting fragments were introduced into
pBAD18 vector digested with NheI and SphI, to yield pELI01,
pELI02, pELI03 and pELI04 plasmids.
Plasmids pELI05 and pELI06 (Table 1) were constructed
by generating PCR fragments encoding the kis and kis74
alleles using primers KIS5N (+)( 5 ′-GGCGAGCATATGGAGG
TGAAGAAT-3′, NdeI site underlined) and KIS CTR (-)( 5 ′-
GCTGGATCCTCAGATTTCCTCCTGAC-3′ which introduces
a BglII site) and plasmids pET80 and pAB1120, respectively,
as DNAtemplates. PCR products bearing the kis alleles were
introduced into pFUS2 after being digested with NdeI and
BglII, resulting in the pELI05 and pELI06 plasmids.
To construct the pELI07 plasmid, a PCR fragment encod-
ing relE was generated using primers relE1B and relE2
described in Gotfredsen et al. (1998) and genomic DNA from
W3110 as template. The PCR product containing relE was
introduced into pNDM220 after being digested with BamHI
and SalI, yielding the pELI07 plasmid.
The pELI08 plasmid was constructed using a fragment
containing the wild-type prfA gene generated from the diges-
Table 4. Strains used in this work.
Strain Genotype Reference
BL21 (DE3) F
- ompT hsdSB (rB
- mB
-) gal dcm lDE3 Novagen
MC1061 F
- araD139 galE15 galK16 rpsL hsdR2 (rK- mK+) mcrA mcrB1 E. coli Genetic Stock Center
KR19 (KR2) MC1061 prfA301 This work
KR4 MC1061 prfA303 This work
KR17 MC1061 prfA121 This work
MRA8 prfA1(ts) Zhang et al. (1994)
W3110 F
- l
- rph-1 INV(rrnD, rrnE) Bachmann (1972)
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vector cleaved with the same enzymes.
The pELI09 plasmid was constructed by introducing a PCR
fragment encoding relB into pFUS2 after a double digestion
with NdeI and HindIII. The PCR fragment was generated
using W3110 as DNA template and degenerated primers
relB1 and relB2 described in Gotfredsen and Gerdes (1998),
relB1 (5′-CCCCCGCATATGTAATTACAAGAGGTGTAAGAC-
3′) and relB2 (5′-CCCCCTCGAGAAGCTTCAGAGTTCAT
CCAGCGTCACACGTACT-GG-3′).
pKK1120 (p15a, kis74, kid) was constructed by ligating the
1.2 kb FspI–EcoRI fragment of pAB1120 containing the kis74
(amber)-kid mutant operon and the 3.8 kb EcoRI–ScaI vector
fragment from pACYC184.
Western blotting for readthrough assay
Cultures growing overnight in LB media were diluted 1:100
and induced with 1% arabinose when the OD600 reached 0.1.
At OD600 0.3, aliquots of 2 ml were centrifuged and the pellet
was re-suspended in 60 ml of Laemmli buffer (Laemmli, 1970)
and boiled for 10 min in order to obtain the cell lysates.
Sodium dodecyl sulphate polyacrylamide gel electrophoresis
(SDS-PAGE) was performed with a Hoefer SE 260 apparatus
in the presence of running buffer [Tris 0.025 M, glycine
0.192 M, SDS 0.1% (w/v) pH 8.5]. The separating gel con-
tained 15% (w/v) of acrylamide. Following electrophoresis,
proteins were transferred onto polyvinylidene diﬂuoride
(PVDF) membrane (Sequi-Blot
TM Bio-Rad Laboratories)
using a Trans-Blot SD Semi-Dry Transfer Cell apparatus (Bio-
Rad Laboratories) at a constant current of 12 V for 90 min at
room temperature. PVDF membrane was blocked overnight
in 137 mM NaCl, 0.1% (w/v) Tween 20 and 20 mM Tris/HCl,
pH 7.5 (buffer TBST), at room temperature. The membrane
was incubated for 1 h with the anti-Kis antibody diluted ¥2000
in buffer TBST. The membrane was then washed four times
by gentle agitation in buffer TBST for 30 min, incubated for
1 h with an anti-rabbit Ig linked to horseradish peroxidase and
diluted ¥10 000 (Amersham Biosciences) in buffer TBST.
Subsequently the membrane was washed four times in buffer
TBST for 30 min, the labelled Kis were revealed with
enhanced chemiluminescence (ECL) detection system
(Amersham Biosciences). Agfa ﬁlms were exposed to the
membranes and developed.
Assay for termination efficiency in vivo
Plasmids expressing MalE, fused to LacZa through a window
containingtheRF2frameshiftsite,wereasdescribedbyPoole
et al. (1995). Parental and prfA mutant strains were trans-
formedandgrowninLBmediumcontaining200 mgm l
-1strep-
tomycin and 200 mgm l
-1 ampicillin to an OD600 of 0.5 and
inducedwith1 mMIPTGfor2 h.Cellproteinsweresolubilized
in SDS gel loading buffer and 3 or 6 ml aliquots were analysed
by SDS-PAGE electrophoresis as described by Poole et al.
(1995). Transfer to nitrocellulose membranes (Hybond C
Super, GE Healthcare) and Western blotting with anti-MalE
antibodies (Anti-MBP-antiserum, NEB) diluted ¥5000 were
performed as described by Sambrook et al. (1989), using
125I-labelledproteinA(GEHealthcare).Radioactivitywasmea-
sured using a phosphorimager (Molecular Dynamics).
Western blotting of MalE fusion proteins
Cultures of strains transformed with plasmids expressing the
MalE fusion proteins were grown in LB medium, 200 mgm l
-1
streptomycin, 200 mgm l
-1 ampicillin and induced with 1 mM
IPTG as described for in vivo termination efficiency
experiments. Aliquots of 1 ml of culture were centrifuged and
the cells were lysed for 10 min at 100°C in 200 ml of lysis
buffer (50 mM Tris-HCl, pH 6.8, 100 mM DTT, 2% SDS, 0.1%
bromophenol blue, 10% glycerol). Aliquots of 20 mli nt h e
case of the parental strain MC1061 and volumes containing
equivalent amounts of total protein in the case of the mutant
strains were applied to 10% polyacrylamide gels for separa-
tion as described by Laemmli (1970). Transfer to nitro-
cellulose membranes, Western blotting with antibodies and
quantiﬁcation were performed as described above. Western
blots were performed with rabbit anti-RF1 diluted ¥5000 com-
mercially prepared from pure factor.
Complementation assays
Cultures of strain MRA8 (prfA1ts) bearing pBAD-derivative
plasmids (prfA wild type and mutants) were grown overnight
at 30°C prior to being diluted 1:100 into two different aliquots
of fresh medium (LB medium; ampicillin, 25 mgm l
-1), with or
without arabinose (0.2% v/v). The cultures were transferred
to 42°C, and the OD600 of both cultures was monitored every
20 min over a period of 160 min.
Toxicity assays
MC1061 wild-type and prfA mutant strains bearing
pNDM220-derivative plasmids containing or not pELI08 were
grown at 30°C to mid-exponential phase in LB broth plus
ampicillin (50 mg ml
-1) and kanamycin (as needed, 50 mg ml
-1).
The same strains containing the pFUS2 derivatives contain-
ing the antitoxin genes were grown in a similar way. Aliquots
of the different cultures and serial dilutions (10
-1 steps) were
spotted onto plates of the same solidiﬁed medium containing
or not IPTG 100 mM as inducer of the toxins and were incu-
bated at 30°C for 18 h. Antitoxins were induced using 0.5%
arabinose. A semi-quantitative assessment of the relative
levels of toxicity was derived from the differential dilution
factor obtained for two spots presenting an equivalent
number of colonies. Similar procedures were used to test the
differential sensitivity of KR19 and MC1061 strains to the
different antibiotics.
In vivo de novo synthesis of 35S-labelled proteins
One millilitre of cultures of wild-type and mutant strains KR19
bearing pSS100 (kid) plus or not pELI08 (prfAwt) or pELI05
(kis), or KR19 bearing pELI07 (relE) plus or not pELI08
(prfAwt) or pELI09 (relB) were labelled with 14.3 mCi of
[
35S]Met/Cys (80:20, Amersham Biosciences) for 2 min at
37°C, then 1 mg of unlabelled methionine was added and
incubation was continued for 8 min at 37°C. Cells were cen-
trifuged at 20 000 g for 2 min at 4°C, the pellet was washed
with a buffer containing KCl 3 mM, NaCl 68 mM, KH2PO4
1.5 mM and NaH2PO4 9 mM and re-suspended in 10 mlo f
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SDS, 0.01 M EDTA 25% (w/v), Bromophenol blue 0.5 g l
-1
and b-mercaptoethanol 5% (v/v)]. Proteins were separated
by 12.5% SDS-PAGE and the radiolabelled products were
identiﬁed by autoradiography.
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